Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9996)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 16, 2018 (publication date) through Jan 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei XF, Ke Y, Bao TH, Tang HR, Wu XS, Shi ZT, Lin J, Zhang ZX, Gu H, Wang L. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World J Clin Cases 2018; 6(5): 74-83 [PMID: 29774219 DOI: 10.12998/wjcc.v6.i5.74] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v6/i5/74.htm |
| Number | Citing Articles |
| 1 |
Chiuyen Phan, Ziyang Zheng, Jianwei Wang, Qiwen Wang, Xiurong Hu, Guping Tang, Hongzhen Bai. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex. Biomaterials Science 2019; 7(11): 4758 doi: 10.1039/C9BM01190K
|
| 2 |
Ruihua Duan, Fen Gong, Yan Wang, Caixia Huang, Jiaming Wu, Leihao Hu, Min Liu, Shijun Qiu, Liming Lu, Yisheng Lin. Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-02961-7
|
| 3 |
Zhenzhen Zhang, Yanfang Wu, Tanghui Zheng, Xiaochun Chen, Guobin Chen, Hong Chen, Xinkun Guo, Susu Zheng, Xiaoying Xie, Boheng Zhang. Efficacy of Transarterial Chemoembolization Combined with Molecular Targeted Agents for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis. Cancers 2022; 14(15): 3710 doi: 10.3390/cancers14153710
|
| 4 |
Jiaye Long, Baoxiang Chen, Zhaohui Liu. Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1179431
|
| 5 |
Daniel H. Palmer, Katerina Malagari, Laura M. Kulik. Role of locoregional therapies in the wake of systemic therapy. Journal of Hepatology 2020; 72(2): 277 doi: 10.1016/j.jhep.2019.09.023
|
| 6 |
Tao Zhang, Weisen Huang, Haorong Dong, Yijun Chen. Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?. Medicine 2020; 99(29): e20962 doi: 10.1097/MD.0000000000020962
|
| 7 |
Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02017-0
|
| 8 |
María Hernández‑bule, María Martínez, María Trillo, Lidia Martínez, Elena Toledano‑Macías, Alejandro Úbeda. Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13068
|
| 9 |
Shanshan Liu, Yunwei Han, Zhihong Zhang, Fei Wu. Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study. Clinical Medicine Insights: Oncology 2023; 17 doi: 10.1177/11795549221146648
|
| 10 |
Ao Huang, Xin-Rong Yang, Wen-Yuan Chung, Ashley R. Dennison, Jian Zhou. Targeted therapy for hepatocellular carcinoma. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00264-x
|